http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107641653-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107641653-B |
| titleOfInvention | Application of MACC1-AS1 probe in preparation of diagnostic reagent for predicting clinical prognosis of gastric cancer |
| abstract | The invention belongs to the field of functions and applications of genes and RNA, and relates to an application of a MACC1-AS1 probe in preparation of a diagnostic reagent for predicting clinical prognosis of gastric cancer. The invention also provides a diagnostic kit for predicting the clinical prognosis of gastric cancer, which comprises the MACC1-AS1 probe. The invention discloses that MACC1-AS1 is positively correlated with prognosis of a patient with gastric cancer, clinical staging of the patient and TNM staging in the gastric cancer for the first time; is an important molecule for generating antioxidant substances to maintain redox balance, promoting glycolysis to maintain glycometabolism, maintaining survival and reducing apoptosis when gastric cancer cells are subjected to sugar-free stress. Therefore, the invention provides theoretical basis and clinical basis for researching relevant factors of clinical prognosis of gastric cancer patients and clinical application of non-coding RNA. |
| priorityDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 373.